Back to Search

STEPHANIE MARKOVINA, MD

MD

Radiation Oncology Physician

NPI: 1336464536IndividualAccepts Medicare

Specialties, Licenses & Credentials

Radiation Oncology PhysicianPrimary

Radiology — Radiation Oncology

Code: 2085R0001X

2015013729(MO)

Education

UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE

Class of 2010

Research & Publications (9)

Common variable immunodeficiency with regulatory T-cell deficiency treated with rapamycin.
PMID 19230472·Ann Allergy Asthma Immunol·2009
5-case
Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma cells.
PMID 18708367·Mol Cancer Res·2008
8-other
DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells.
PMID 18314485·Mol Cancer Res·2008
7-preclinical
Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma.
PMID 18489772·Mol Cancer·2008
7-preclinical
Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IkappaBalpha degradation in B cells.
PMID 15922723·Exp Cell Res·2005
7-preclinical
Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
PMID 14695217·Cancer Res·2003
7-preclinical
Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
PMID 12214272·Oncogene·2002
8-other
Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase.
PMID 11606413·Cancer Res·2001
8-other
Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
PMID 11118054·Cancer Res·2000
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4921 PARKVIEW PL, SITEMAN CANCER CENTER LOWER LEVEL
SAINT LOUIS, MO 63110

Location

Practice Location

4921 PARKVIEW PL, SAINT LOUIS, MO
(314) 747-7236

Quick Facts

NPI
1336464536
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
16
Publications
9

Are you this provider?

Claim Your Profile